Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Oct 20 - Oct 25
Retatrutide is a triple agonist that targets GLP-1, GIP, and glucagon receptors
FDA approval for Zepbound in treating sleep apnea was based on two previous Eli Lilly-sponsored trials published in the New England Journal of Medicine involving nearly 470 participants, some of whom were using continuous positive airway pressure (CPAP) machines, a standard treatment for OSA
Food and Drug Administration (FDA) Research from Tufts Medical Center J.P
BPC-157 Vial is a synthetic research peptide investigated in laboratory settings to examine peptide structure, stability, and molecular interaction models
US$ 23.34
US$ 29.57
US$ 22.80
US$ 25.33
